Navigation Links
Screen of existing drugs finds compounds active against MERS coronavirus
Date:5/20/2014

WHAT:

Clinicians treating patients suffering from Middle East respiratory syndrome (MERS) currently have no drugs specifically targeted to the MERS coronavirus (MERS-CoV), a virus first detected in humans in 2012 that has since caused 614 laboratory-confirmed infections, including 181 that were fatal, according to the World Health Organization. The case count escalated sharply in the spring of this year, and the first cases in the United States were announced in early May. To address the urgent need for therapies, researchers supported by the National Institutes of Health screened a set of 290 compounds already approved by the U.S. Food and Drug Administration or far advanced in clinical development for other indications to determine if any might also show potential for working against MERS-CoV.

From the group of 290 compounds, the scientists identified 27 that, in test tube experiments, showed activity against both MERS-CoV and the related SARS coronavirus. These included compounds that inhibited the viruses' ability to enter and infect cells. The active compounds belong to 13 different classes of pharmaceuticals, including drugs normally used to treat cancer and psychiatric conditions, and provide leads for continued study in animals and potentially for study in people. The research team is now studying the effects of some of the identified compounds in mice experimentally infected with MERS-CoV.

"Given development times and manufacturing requirements for new products, repurposing of existing drugs is likely the only solution for outbreaks due to emerging viruses," the investigators noted in the paper now online in the journal Antimicrobial Agents and Chemotherapy. The research was a collaboration between investigators at the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health, and Matthew B. Frieman, Ph.D., of the University of Maryland School of Medicine in Baltimo
'/>"/>

Contact: Anne A. Oplinger
aoplinger@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
Source:Eurekalert

Page: 1 2

Related medicine news :

1. IntegraGen launches ARISk test, a genetic screening tool for autism in high-risk children
2. Obese White Women Shying Away From Colon Cancer Screening
3. Lung Cancer Screening Might Pay Off, Analysis Shows
4. U.S. Panel Rejects Ovarian Cancer Screening
5. AstraZeneca and DNDi to collaborate on drug screening for neglected tropical diseases
6. Role of Screening, Monitoring in Early Kidney Disease Unclear
7. Screening programs detect cases of undiagnosed rheumatic heart disease in low-resource countries
8. Additional blood pressure screening may reduce incidence of CVD events and death by up to 3 percent
9. Routine Kidney Disease Screening Not Worthwhile, Experts Say
10. Risk factors may inform breast cancer screening
11. Research examines when benefits of screening mammography outweigh the harms for women in their 40s
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... CA (PRWEB) March 26, 2015 The American ... will be on the topics of the DAOM Program as ... DAOM Program Overview Webinar will be hosted by Dr. Carla ... provide the next steps on how to prepare for the ... p.m. March 25, March 27, April 1 and April 3. ...
(Date:3/26/2015)... Doctors Scott Sullivan and Frank DellaCroce, Co-Founders of the ... the St. Charles Surgical Hospital (SCSH) in ... Surgical Oncologist Dr. William Karl Ordoyne has joined their ... surgical oncologist Alan Stolier, M.D., FACS and the team ... Sullivan, M.D., FACS; Chris Trahan, M.D., FACS; M. Whitten ...
(Date:3/26/2015)... PA (PRWEB) March 26, 2015 The ... a new team of nationally renowned scientists to focus ... B, a move that nearly triples its research capacity ... focusing solely on hepatitis B and liver cancer in ... Timothy Block, Jinhong Chang, Ju Tao Guo and Ying-Hsiu ...
(Date:3/26/2015)... 2015 Behavioral Research Group, LLC ... the release of BathroomMap® , a new bathroom ... to public restrooms for travelers, especially those with medical ... does not facilitate a paid, social or crowdsourced model, ... rate local establishments that have clean, available restrooms in ...
(Date:3/26/2015)... Visiting Nurse Association of Northern New Jersey ... Lighting the Way, Brightening the Day, on Friday, May ... in Morristown, NJ. , Guests will enjoy an ... Clemente, delightful cuisine, an extensive silent auction and heart-warming ... prestigious awards will be presented to this year’s honorees. ...
Breaking Medicine News(10 mins):Health News:ACTCM Announces Upcoming Webinars 2Health News:Surgical Oncologist Joins Center for Restorative Breast Surgery and St. Charles Surgical Hospital 2Health News:Surgical Oncologist Joins Center for Restorative Breast Surgery and St. Charles Surgical Hospital 3Health News:Baruch S. Blumberg Institute Recruits World-Class Hepatitis B Scientists 2Health News:Baruch S. Blumberg Institute Recruits World-Class Hepatitis B Scientists 3Health News:Baruch S. Blumberg Institute Recruits World-Class Hepatitis B Scientists 4Health News:New Bathroom Finder App, BathroomMap®, Helps People with Medical Needs Who Urgently Need a Bathroom When Traveling 2Health News:New Bathroom Finder App, BathroomMap®, Helps People with Medical Needs Who Urgently Need a Bathroom When Traveling 3Health News:Morristown VNA Fundraiser to Honor Distinguished Community Members 2
... China Yingxia,International, Inc. (OTC Bulletin Board: CYXI) ... the nutraceutical industry engaged in the,development, manufacture ... and personal care products in the People,s ... has retained CCG Elite to design,and execute ...
... About the Importance of Regular Eye Care, ... the nationwide launch of its "See America" contest, ... preventive eye exams to promote,overall vision health. The ... sight will award the grand prize winner,with the ...
... Clinicogenomic Model Has Highest Prediction Accuracy for Lung ... an emerging,leader in the field of molecular diagnostics ... model for lung cancer diagnosis in the,inaugural edition ... American Association for Cancer Research (AACR), which is ...
... to expand the $200 million surgical ... Group, WALTHAM, Mass., April 14, 2008 According ... 2008 report,the surgical navigation market was worth almost $200 ... five years. This growth will be partly,facilitated by soft ...
... BioElectronics President, CEO, and Chairman Issues Shareholder ... Andrew Whelan,President, CEO and Chairman of BioElectronics, ... FDA-cleared, drug-free anti-inflammatory patch,with an embedded battery ... relieve pain and speed healing, today issued ...
... 14 The rating,agency Standard & Poor,s has raised ... stable". This means that Gerresheimer is now only one,step ... justification for the upgrade, Standard & Poor,s emphasises the,positive ... EBITDA.,Gerresheimer, it says, will be able to sustain this ...
Cached Medicine News:Health News:China Yingxia International, Inc. Retains CCG Elite 2Health News:China Yingxia International, Inc. Retains CCG Elite 3Health News:Prevent Blindness America Invites Consumers to 'See America' Through Nationwide Contest 2Health News:Prevent Blindness America Invites Consumers to 'See America' Through Nationwide Contest 3Health News:Prevent Blindness America Invites Consumers to 'See America' Through Nationwide Contest 4Health News:Allegro Diagnostics Announces Publication in Cancer Prevention Research of Prediction Model for Lung Cancer Diagnosis Integrating Clinical and Genomic Features 2Health News:Allegro Diagnostics Announces Publication in Cancer Prevention Research of Prediction Model for Lung Cancer Diagnosis Integrating Clinical and Genomic Features 3Health News:New Technology Promises Safer Organ Transplants and Soft Tissue Surgeries 2Health News:New Technology Promises Safer Organ Transplants and Soft Tissue Surgeries 3Health News:BioElectronics CEO Andrew Whelan: Positioning the Company for Growth During 2008 and Beyond 2Health News:BioElectronics CEO Andrew Whelan: Positioning the Company for Growth During 2008 and Beyond 3Health News:BioElectronics CEO Andrew Whelan: Positioning the Company for Growth During 2008 and Beyond 4Health News:Standard & Poor's Raises Gerresheimer Rating to BB+ 2
(Date:3/26/2015)... -- Huntington Memorial Hospital is the first facility in ... replacement (TAVR), a minimally invasive replacement of heart valves. ... replace an aortic valve without a chest incision or ... The procedure is performed by a dedicated Huntington Hospital ... , MD, interventional cardiologist and Robbin Cohen , ...
(Date:3/26/2015)... S.C. , March 26, 2015 ... told by their existing PACS vendor their system ... (CMH) determined that they needed a better structured ... Hospital selected Avreo interWORKS due to its interface ... modern meaningful use standards through to the hospital,s ...
(Date:3/26/2015)... , March 26, 2015  Desert Valley Medical Center, ... times , is the first U.S. hospital to ... emergency department to help clinicians prevent hospital acquired pressure ... Victorville, Calif. , is a community hospital serving ... Using the Leaf Patient Monitor in the hospital,s emergency ...
Breaking Medicine Technology:Huntington Memorial Hospital Performs Groundbreaking Minimally Invasive Replacement of Heart Valves 2Clinch Memorial Hospital Modernizes Workflow with Avreo interWORKS 2Desert Valley Medical Center First to Use Leaf Healthcare Patient Wearable Technology in its ED as Part of Hospital-wide Deployment 2Desert Valley Medical Center First to Use Leaf Healthcare Patient Wearable Technology in its ED as Part of Hospital-wide Deployment 3
... within 5,minutes of dosing and is well-tolerated , ... Ltd,("Archimedes"), a European specialty pharmaceutical company, today,presented new ... Nasalfent(r),an innovative fentanyl citrate nasal spray aimed at ... cancer,pain. Data were presented at the 10th Congress ...
... dosed every two weeks achieved an SVR rate ... analysis), with,more favorable quality-of-life scores -, ROCKVILLE, Md., ... today announced the top-line final results of,a Phase ... with ribavirin in treatment-naive patients with,genotype 1 chronic ...
Cached Medicine Technology:Archimedes Pharma Presents Positive Efficacy and Safety Data on,Nasalfent at European Association for Palliative Care Congress 2Archimedes Pharma Presents Positive Efficacy and Safety Data on,Nasalfent at European Association for Palliative Care Congress 3Human Genome Sciences Announces Positive Final Results Of Phase 2b,Trial of Albuferon 2Human Genome Sciences Announces Positive Final Results Of Phase 2b,Trial of Albuferon 3Human Genome Sciences Announces Positive Final Results Of Phase 2b,Trial of Albuferon 4Human Genome Sciences Announces Positive Final Results Of Phase 2b,Trial of Albuferon 5Human Genome Sciences Announces Positive Final Results Of Phase 2b,Trial of Albuferon 6Human Genome Sciences Announces Positive Final Results Of Phase 2b,Trial of Albuferon 7Human Genome Sciences Announces Positive Final Results Of Phase 2b,Trial of Albuferon 8
Architect i2000 is a flexible solution for your evolving laboratory providing high throughput and walkaway time with built-in flexibility....
Innotrac Aio! immunoanalyzers are specially designed to exploit the benefits of Innotrac Diagnostics' exclusive dry chemistry and non-enhancement time-resolved fluorometry....
... immunoassay system is a ... analyzer that performs a ... panels that include anemia, ... disease, blood virus, skeletal, ...
...
Medicine Products: